Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solid Biosciences

3.26
+0.22007.24%
Post-market: 3.25-0.0100-0.31%16:23 EDT
Volume:1.19M
Turnover:3.79M
Market Cap:252.70M
PE:-1.07
High:3.29
Open:3.05
Low:3.00
Close:3.04
Loading ...

Solid Biosciences Down 10.5%, Taysha Gene Therapies Down 14%

THOMSON REUTERS
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

Reuters
·
31 Mar

BUZZ-Gene therapy makers slide on reports that FDA official Peter Marks resigns

Reuters
·
31 Mar

Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month

Insider Monkey
·
15 Mar

Solid Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
10 Mar

Solid Biosciences price target raised to $20 from $16 at H.C. Wainwright

TIPRANKS
·
10 Mar

Solid Biosciences Inc. : H.c. Wainwright Raises Target Price to $20 From $16

THOMSON REUTERS
·
10 Mar

Solid Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
08 Mar

Solid Biosciences (SLDB) Gets a Buy from Chardan Capital

TIPRANKS
·
08 Mar

Solid Biosciences Price Target Maintained With a $15.00/Share by Citizens Capital Markets

Dow Jones
·
07 Mar

Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade

Zacks
·
07 Mar

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

Zacks
·
07 Mar

Solid Biosciences Inc expected to post a loss of 60 cents a share - Earnings Preview

Reuters
·
07 Mar

Barclays Remains a Buy on Solid Biosciences (SLDB)

TIPRANKS
·
07 Mar

Solid Biosciences: Positive DMD Program Developments and Strong Financial Position Justify Buy Rating

TIPRANKS
·
07 Mar

Solid Biosciences files to sell 975,496 shares of common stock for holders

TIPRANKS
·
07 Mar

Solid Biosciences reports Q4 EPS ($1.00), consensus (78c)

TIPRANKS
·
07 Mar

Solid Biosciences Inc: Anticipated Cash Runway Into First Half of 2027

THOMSON REUTERS
·
07 Mar

Solid Biosciences Q4 2024 GAAP EPS $(1.00) Misses $(0.81) Estimate

Benzinga
·
07 Mar

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
07 Mar